Novartis Sale Of US Oral Generics Unit Seems Unlikely

 
• By Kevin Grogan
  
Plan
Sandoz is weighing up options for its US oral generics business • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business